Ohnaga Yoshiyuki, Saito Yuichi, Mori Yuichiro, Kato Ken, Tateishi Kazuya, Kitahara Hideki, Kobayashi Yoshio
Department of Cardiovascular Medicine, Chiba University Hospital, Chiba, Japan.
Department of Cardiovascular Medicine, Chiba University Hospital, Chiba, Japan.
JACC Adv. 2025 May 14;4(6 Pt 1):101790. doi: 10.1016/j.jacadv.2025.101790.
Although intracoronary acetylcholine (ACh) provocation testing is a guideline-recommended invasive standard for the diagnosis of vasospastic angina (VSA), ACh tests are largely underused in clinical practice globally. Recently, the ABCD score, consisting of clinical presentation, myocardial bridge, C-reactive protein, and dyslipidemia, was developed to predict positive ACh test results.
The authors aimed to externally validate the diagnostic ability of the score and attempted to improve the predictivity for identifying patients with VSA.
From May 2012 to September 2023, a total of 723 patients undergoing ACh provocation tests for diagnosing VSA were included. The original ABCD score was calculated according to the predefined criteria, and the modified ABCD score was internally developed to improve the diagnostic accuracy. The positive ACh provocation test (ie, VSA) was defined as a significant angiographic vasospasm accompanied by chest pain and/or ischemic electrocardiographic changes.
Of the 723 patients, 383 (53.0%) had positive ACh provocation test results. The receiver-operating characteristics curve analysis indicated that the original ABCD score was significantly predictive of positive ACh tests. Using best cutoff values on receiver-operating characteristics curve analyses, we developed the modified ABCD score, which was simpler than the original score. The modified rather than original ABCD score had better diagnostic ability for positive ACh test results (area under the curve 0.65 vs 0.55; P < 0.001).
The original ABCD score was predictive of VSA in this external validation study with modest diagnostic accuracy, while the modified ABCD score achieved better predictivity for identifying patients with VSA.
尽管冠状动脉内乙酰胆碱(ACh)激发试验是诊断血管痉挛性心绞痛(VSA)的指南推荐的侵入性标准,但ACh试验在全球临床实践中大多未得到充分利用。最近,由临床表现、心肌桥、C反应蛋白和血脂异常组成的ABCD评分被开发出来,以预测ACh试验阳性结果。
作者旨在对该评分的诊断能力进行外部验证,并试图提高识别VSA患者的预测性。
纳入2012年5月至2023年9月期间共723例接受ACh激发试验以诊断VSA的患者。根据预定义标准计算原始ABCD评分,并内部开发改良的ABCD评分以提高诊断准确性。ACh激发试验阳性(即VSA)定义为伴有胸痛和/或缺血性心电图改变的显著血管造影血管痉挛。
723例患者中,383例(53.0%)ACh激发试验结果为阳性。受试者工作特征曲线分析表明,原始ABCD评分对ACh试验阳性具有显著预测性。通过在受试者工作特征曲线分析中使用最佳截断值,我们开发了改良的ABCD评分,其比原始评分更简单。改良的而非原始的ABCD评分对ACh试验阳性结果具有更好的诊断能力(曲线下面积分别为0.65和0.55;P<0.001)。
在这项外部验证研究中,原始ABCD评分对VSA具有预测性,但诊断准确性一般,而改良的ABCD评分在识别VSA患者方面具有更好的预测性。